Clinical Trials Logo

Filter by:
NCT ID: NCT02572518 Completed - Yellow Fever Clinical Trials

Immunity After Two Doses of Yellow Fever Vaccine

IATDYFV
Start date: May 2014
Phase: N/A
Study type: Observational [Patient Registry]

To evaluate the immune status of yellow fever in adults with a history of two or more doses of vaccine, having received the second dose for at least 1 year, compared to re-vaccinated individuals (second dose) after 30 days.

NCT ID: NCT02571244 Completed - Clinical trials for Tobacco Use Disorder

Text Messaging for Supporting Quit Attempts

Start date: June 2015
Phase: N/A
Study type: Interventional

This study is a preliminary research aimed to compare the feasibility and effectiveness of motivational interview (MI), Personalized text messages (TM) and usual care for outpatients, with focus on smoking cessation as the main outcome. Smokers patients have received brief interventions and nicotine replacement therapy during the hospitalization. After discharge smokers were allocated into a intervention or control arm. In the first and third months, after randomization, the patients were contact to smoke abstinence assessment.

NCT ID: NCT02570633 Completed - Migraine Clinical Trials

Ginger Capsules for the Prophylactic Treatment of Migraine

Start date: April 2015
Phase: N/A
Study type: Interventional

The main objective of the study is to evaluate ginger efficacy as an prophylactic treatment of migraine.

NCT ID: NCT02569866 Completed - Clinical trials for Surgical Site Infection

Antibiotics After Breast Reduction:Clinical Trial With Randomization

Start date: November 2014
Phase: Phase 2
Study type: Interventional

This study was designed to determine the role of antibiotics reduction mammaplasty influence surgical site infections rates.

NCT ID: NCT02568722 Completed - Acute Kidney Injury Clinical Trials

Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)

Start date: October 2015
Phase: N/A
Study type: Interventional

The objectives of this trial are to determine whether, in critically ill patients with severe acute kidney injury (AKI), randomization to accelerated initiation of renal replacement therapy (RRT), compared to standard initiation, leads to: 1. Improved survival (primary outcome); and 2. Recovery of kidney function (principal secondary outcome), defined as independence from RRT at 90 days

NCT ID: NCT02568670 Completed - Phlebitis Clinical Trials

Removal Peripheral Intravenous Catheters According to Clinical Signs or Every 96 Hours: A Non Inferiority Study

ResPeCt
Start date: November 2015
Phase: N/A
Study type: Interventional

This is a two-centers, open label, prospective, randomized, noninferiority controlled trial with cost-effectiveness analysis to verify if is non inferior to remove peripheral intravenous catheter according to clinical signs in relation to every 96 hours.

NCT ID: NCT02566993 Completed - Clinical trials for Small-cell Lung Cancer

Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer

ATLANTIS
Start date: August 30, 2016
Phase: Phase 3
Study type: Interventional

Phase III randomized clinical trial of lurbinectedin (PM01183)/doxorubicin (DOX) versus cyclophosphamide (CTX), doxorubicin (DOX) and vincristine (VCR) (CAV) or topotecan as treatment in patients with small-cell lung cancer (SCLC) who failed one prior platinum-containing line.

NCT ID: NCT02564822 Completed - Migraine Disorders Clinical Trials

Effects of the Visual Stimulation on the Motor and Visual Cortex in Migraneurs With and Without Aura

Start date: July 2015
Phase:
Study type: Observational

The aim of this study is to investigate the motor and visual cortex excitability in response to visual stimulation of migraineurs with and without aura compared to healthy individuals. For this purpose, electrical cortical activity of migraineurs will be compared to healthy volunteers.

NCT ID: NCT02563054 Completed - Gastric Cancer Clinical Trials

A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer

Start date: April 2003
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of oral capecitabine (Xeloda) versus 5-fluorouracil (5-FU), in combination with intravenous (IV) cisplatin, in participants with advanced and/or metastatic gastric cancer. The anticipated time on study treatment is at least 6 weeks and continued up to disease progression, and the target sample size is 300 individuals.

NCT ID: NCT02562586 Completed - Osteoarthritis, Hip Clinical Trials

Is Drainage Necessary After Total Hip Replacement?

Start date: May 2014
Phase: N/A
Study type: Interventional

The goal of this study was to compare early results of Total Hip Replacement (THR) in 2 groups of patients: with and without closed suction drainage (CSD). Patients were followed for 3 months post operatively.